Cullinan
Cullinan Secures $280M in Private Placement to Enter Autoimmune Market
Cullinan, Private Placement, $280M, Autoimmune Market, Biotechnology
Actionable Insights Powered by AI
Cullinan, Private Placement, $280M, Autoimmune Market, Biotechnology